User: Guest

OPTICAL IMAGING TECHNIQUES

Global Market Trajectory & Analytics

MCP13750

VALIDATED EXECUTIVE ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

6811

Interactions with Platform & by Email *

INTERACTIONS

1092

Unique # Participated *

PARTICIPANTS

204

Responses Validated *

VALIDATIONS

92

* Login to view program details and full enterprise executive list.


  •  DATE

    JULY 2020

  •  TABLES

    312

  •  PAGES

    544

  •  EDITION

    8

  •  PRICE

    USD $4950


GLOBAL EXECUTIVE SURVEY

Impact of Pandemic & Economic Slowdown

Monitor Market Dynamics!
Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.

The global market for Optical Imaging is projected to reach US$2.5 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more powerful imaging technologies. Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures; easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Optical medical imaging is the newest imaging technology capable of revolutionizing healthcare in ways hitherto unimagined. Defined as the use of light to visualize cellular and molecular functions in a living body, optical imaging revolves around the use of photons in light to generate images. Light of various wavelengths are used ranging from ultraviolet to near infrared. Fluorescence protein imaging has huge potential in cancer screening given its ability to accurately detect lesions, monitor tumor growth and evaluate patient response to therapy. The technology revolves round the use of endogenous or exogenous materials that illuminate when activated by an external light source.

Endoscopy is the most simple and widely used type of optical imaging that utilizes a flexible tube to deliver light to targeted organs for visualization. Demand for advanced endoscopic imaging is poised to benefit from the growing preference for minimally invasive surgeries and growing penetration of endoscopy in multiple applications such as esophagus, stomach, ulcerative colitis and Crohn's disease, gallstones, hiatal hernia, vaginal bleeding, etc. The wide array of endoscopies available stands testimony to the ubiquity of this technology i.e. arthroscopy, bronchoscopy, colonoscopy, cystoscopy, enteroscopy, hysteroscopy, laparoscopy, laryngoscopy, mediastinoscopy and sigmoidoscopy, ureteroscopy, esophagogastroduodenoscopy and thoracoscopy. Optical Coherence Tomography (OCT) is used widely in ophthalmology and cardiology and involves the use of light waves to generate in-vivo cross sectional views of diseased tissues. The growing burden of cardiovascular diseases which currently stands at billions of dollars worldwide is a major revenue draw for OCT. Photoacoustic Imaging is also used in cancer tumor monitoring and involves delivering heat generating laser pulses to tissues that expand tissues and enable their imaging. The epidemic spread of cancer bodes well for this technology. In vivo optical imaging using fluorescence and bioluminescence is also invaluable and superior to other methods of imaging. With global cancer burden as measured by new cancer diagnosis poised to reach over 20 million per year by 2020, effective optical methods for cancer imaging will grow in prominence. Diffuse Optical Tomography (DOT) is used for imaging of the brain and involves the use of near-infrared light, which when absorbed by the neurons reveals information about the chemical compositions in the brain. The emerging field of neuroscience will offer ample market opportunities for the use of DOT in anesthesia monitoring and also monitoring psychoactive medications used to treat depression and post-traumatic stress disorder, among others. The United States and Europe represent large markets worldwide with a combined share of 70.1% of the market. China ranks as the fastest growing market with a CAGR of 15.3% over the analysis period supported by the country's rapidly developing healthcare system under the “Healthy China 2020” initiative.
» Technique (Optical Coherence Tomography, Hyperspectral Imaging, Near-Infrared Spectroscopy, Photoacoustic Tomography) » Therapeutic Type (Oncology, Ophthalmology, Neurology, Cardiology, and Other Therapeutic Types) » and End-Use (Hospitals & Clinics, Research Laboratories, Pharma & Biotech)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

  • A: 
    ACTIVE CLIENT
  • B: 
    INACTIVE CLIENT
  • C: 
    ACTIVE PANELIST
  • D: 
    INACTIVE PANELIST
  • E: 
    OPT-INS
  
REPORT INDEX PROJECT COMPENDIUM * EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com